Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE8A2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,187
Award facts
- Contract value 100% obligated
- $19,187.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,187.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pens on December 3, 2025, with completion scheduled for December 4, 2025. This non-competitive delivery order represents a single-line pharmaceutical procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves delivery to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary operations as a major pharmaceutical distributor serving federal medical procurement needs.
AmerisourceBergen Drug Corp serves as a critical vendor for the Defense Health Agency and military healthcare systems, supplying a comprehensive range of brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities. The Zepbound procurement falls within the company's broader portfolio of diabetes and metabolic disorder medications supplied through federal contracts. As the prime contractor on this delivery order with no subcontractors identified, AmerisourceBergen continues to support the military health system's pharmaceutical supply chain through its established relationship with DLA, which is responsible for providing medical logistics and supply management across the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FE8A2?
SPE2DR26FE8A2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FE8A2 worth?
The government has obligated $19,187 on SPE2DR26FE8A2.
Is contract SPE2DR26FE8A2 an order under another contract?
Yes. SPE2DR26FE8A2 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FE8A2 competed?
The extent of competition for SPE2DR26FE8A2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award